Evidence map›Paper›PMID 39362283›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2025

Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular Disease.

Abhishek Gami, Vivek P Jani, Hoda Mombeini, Ryan Osgueritchian, Ilton M Cubero Salazar, Matthew Kauffman, Catherine E Simpson, Rachel L Damico, Todd M Kolb, Ami A Shah and 5 more

Abstract read
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Refining Risk Prediction in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abhishek GamiJohns Hopkins University School of Medicine, Baltimore, Maryland.
Vivek P JaniJohns Hopkins University School of Medicine, Baltimore, Maryland.
Hoda MombeiniJohns Hopkins University Division of Cardiology, Baltimore, Maryland.
Ryan OsgueritchianJohns Hopkins University Division of Cardiology, Baltimore, Maryland.
Ilton M Cubero SalazarJohns Hopkins University Division of Cardiology, Baltimore, Maryland.
Matthew KauffmanJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Catherine E SimpsonJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Rachel L DamicoJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Todd M KolbJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Ami A ShahJohns Hopkins University Division of Rheumatology, Baltimore, Maryland.
Stephen C MathaiJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Ryan J TedfordDivision of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.
Steven HsuJohns Hopkins University Division of Cardiology, Baltimore, Maryland.
Paul M HassounJohns Hopkins University Division of Pulmonary and Critical Care Medicine, Baltimore, Maryland.
Monica MukherjeeJohns Hopkins University Division of Cardiology, Baltimore, Maryland. Electronic address: mmukher2@jhu.edu.

Funding

Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAHR01HL114910 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HASSOUN, PAUL M. · 2012 to 2023
$6.2M
Early Detection of Right Ventricular Dysfunction and Emerging Pulmonary Hypertension in Systemic SclerosisR01HL162851 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Monica Mukherjee · 2023 to 2026
$2.5M
Myocyte Mechanics of Right Ventricular Contractile Failure in Pulmonary Hypertension due to Heart Failure with Reduced Ejection FractionR01HL172830 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Steven Hsu · 2024 to 2026
$2.0M
Hopkins Clinical Center for Pulmonary Vascular Disease Phenomics ProgramU01HL125175 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HASSOUN, PAUL M., MATHAI, STEPHEN C · 2015 to 2019
$1.1M
Mechanisms and treatment of right ventricular sarcomere dysfunction in scleroderma-associated pulmonary arterial hypertensionK23HL146889 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HSU, STEVEN · 2019 to 2023
$886k
The role of xanthine oxidoreductase activity and altered metabolism in scleroderma-associated pulmonary arterial hypertensionK23HL153781 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIMPSON, CATHERINE · 2020 to 2024
$883k
Harnessing multivariate patient- and population-level disease trajectories to predict major clinical events in sclerodermaK24AR080217 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Ami Aalok Shah · 2022 to 2026
$847k
NHLBI NIH HHS K23 HL146889NHLBI NIH HHS K23 HL153781NHLBI NIH HHS R01 HL114910NHLBI NIH HHS R01 HL162851NHLBI NIH HHS R01 HL172830NHLBI NIH HHS U01 HL125175NIAMS NIH HHS K24 AR080217
6 · The paper itself

Abstract

backgroundIneffective right ventricular (RV) adaptation to increasing pulmonary arterial (PA) afterload in pulmonary vascular disease (PVD) significantly contributes to morbidity and mortality. Pulmonary vascular disease in systemic sclerosis (SSc) arises through various mechanisms, yet detecting abnormal contractile response remains challenging. Here we examine whether echocardiographic RV-PA coupling metrics correlate with invasive pressure-volume (PV) loops, enhancing the prediction of adverse clinical outcomes in SSc-PVD patients.

methodsProspectively enrolled patients with SSc-PVD with paired echocardiogram and PV loops were included. Linear regression and receiver-operating curve analysis were used to assess the relationship between tricuspid annular plane systolic excursion/PA systolic pressure (PASP), fractional area change/PASP, tissue Doppler velocityS'/PASP, and RV free wall strain (RVFWS)/PASP and coupling thresholds defined by end-systolic to end-arterial elastance (Ees/Ea), obtained by the multibeat method. The contribution of right atrial strain (RAS) to RV-PA coupling parameters was also investigated. Kaplan-Meier analysis was used to identify the relationship between coupling ratios and composite outcomes including clinical worsening, lung transplant, and death.

resultsForty-two patients with SSc were studied, 91% female, with a mean age of 59 ± 12 years and varying degrees of PVD: mean pulmonary artery pressure 29.5 ± 12.8 mm Hg, PVR 4.7 ± 4.2 WU, and PCWP 10.3 ± 4.1 mm Hg. Echocardiographic coupling metrics including tricuspid annular plane systolic excursion/PASP, fractional area change/PASP, tissue Doppler velocity S'/PASP, RVFWS

conclusionEchocardiographic RV-PA coupling ratios strongly correlate with invasive Ees/Ea and predict adverse clinical outcomes in SSc patients across the spectrum of PVD. Further, we demonstrate how RAS impacts RV performance. These findings may refine risk stratification and prognostication in this at-risk cohort.

Indexed as

EchocardiographyEchocardiography, DopplerHeart VentriclesHypertension, PulmonaryPulmonary ArteryScleroderma, SystemicVentricular Function, RightAgedFemaleHumansMaleMiddle AgedPrognosisProspective StudiesMortalityPulmonary hypertensionRight atriumRight ventricleSystemic sclerosis

Identifiers

PMID39362283
PMCPMC11798721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.